Coverage policy updates

Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.

Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.

Recorded changes

86,510 on record

Recorded policy changes, newest first
Recorded	Payer	Policy	Change
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Multispectral Digital Skin Lesion Analysis prnPayerPolicy · BCBSMA-748-8F41659B7C	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Microprocessor Controlled Prostheses for the Lower Limb prnPayerPolicy · BCBSMA-133-E66AAE5E13	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Manual and Power Operated WheelchairsPayerPolicy · BCBSMA-365-4059998D3A	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Leadless Cardiac Pacemakers prnPayerPolicy · BCBSMA-038-1F73D73CA7	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Laser Interstitial Thermal TherapyPayerPolicy · BCBSMA-948-F18E8A849F	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Intracoronary Drug Delivery Balloon ProceduresPayerPolicy · BCBSMA-236-792841E987	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Insulin Delivery Devices prnPayerPolicy · BCBSMA-332-33B3AF240F	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Implantable Peripheral Nerve Stimulation for Chronic Pain ConditionsPayerPolicy · BCBSMA-103-EACC4E18C0	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Extracorporeal Shock Wave Treatment for Plantar Fasciitis and Other Musculoskeletal Conditions prnPayerPolicy · BCBSMA-081-0062204742	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Esophageal pH Monitoring prnPayerPolicy · BCBSMA-069-3C7C2E7FFF	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Electrical Stimulation Devices for Psychiatric and Neurological Conditions prnPayerPolicy · BCBSMA-157-E513478179	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Dynamic Low-Load Prolonged Duration Stretch DevicesPayerPolicy · BCBSMA-405-8AF86A032D	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Durable Medical Equipment DMEPayerPolicy · BCBSMA-842-2B2A2896FA	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Digital Health Technologies Therapeutic ApplicationsPayerPolicy · BCBSMA-090-C57432C393	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Digital Health Technologies Diagnostic ApplicationsPayerPolicy · BCBSMA-175-C3D9BD7623	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Diaphragmatic Phrenic Nerve and Diaphragm Pacing Systems prnPayerPolicy · BCBSMA-593-10EADD3033	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Cooling Devices Used in the Outpatient Setting prnPayerPolicy · BCBSMA-510-D248605A44	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Continuous Passive Motion in the Home Setting prnPayerPolicy · BCBSMA-407-AC5FECB76B	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Continuous or Intermittent Monitoring of Glucose in Interstitial Fluid and Automated Insulin Delivery SystemsPayerPolicy · BCBSMA-107-D1857CF6A7	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Computer-Assisted Navigation Orthopedic Procedure prnPayerPolicy · BCBSMA-594-95E37C7835	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Biventricular Pacemakers - Cardiac Resynchronization Therapy for the Treatment of Heart Failure prnPayerPolicy · BCBSMA-101-C9C93DDF94	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Bioimpedance Devices for the Detection of Lymphedema prnPayerPolicy · BCBSMA-261-34230DE377	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Balloon Spacers for Treatment of Irreparable Rotator Cuffs of the ShoulderPayerPolicy · BCBSMA-176-EFA2F44FF2	New policy
Aug 2, 2026	Blue Cross Blue Shield of Massachusetts	Ambulatory Electrocardiograph (AECG) MonitoringPayerPolicy · BCBSMA-119-4178D178C2	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING - SOMATIC BIOMARKER TESTING (INCLUDING LIQUID BIOPSY) FOR TARGETED TREATMENT AND IMMUNOTHERAPY IN NON-SMALL-CELL LUNG CANCER (EGFR, ALK, BRAF, ROS1, RET, MET, KRAS, HER2, PD-L1, TMB)PayerPolicy · BCBSM-2055797	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	Pressure Gradient Garments and Support StockingsPayerPolicy · BCBSM-2008167	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENE EXPRESSION PROFILE TESTING AND CIRCULATING TUMOR DNA TESTING FOR PREDICTING RECURRENCE IN COLON CANCER (E.G., COLOPRINT, COLON PRS, GENEFX, GUARDANT REVEAL, ONCODEFENDER, ONCOTYPE DX COLON CANCER TEST, SIGNATERA)PayerPolicy · BCBSM-2017374	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING- SOMATIC BIOMARKER TESTING (INCLUDING LIQUID BIOPSY) FOR TARGETED TREATMENT AND IMMUNOTHERAPY IN NON-SMALL-CELL LUNG CANCER (EGFR, ALK, BRAF, ROS1, RET, MET, KRAS, HER2, PD-L1, TMB) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198025	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENE EXPRESSION PROFILE TESTING AND CIRCULATING TUMOR DNA TESTING FOR PREDICTING RECURRENCE IN COLON CANCER (E.G., COLOPRINT¿, COLON PRS, GENEFX¿ COLON, ONCODEFENDER?-CRC, ONCOTYPE DX¿ COLON CANCER TEST, SIGNATERA) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198906	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	BCN ONLY - ELECTRICAL/ELECTROMAGNETIC STIMULATION FOR THE TREATMENT OF ARTHRITIS (updated and renamed Transcutaneous Electrical Joint Stimulation for the Treatment of Arthritis) (unpublished per MedAffairs request 10/21/2020 -kgray)PayerPolicy · BCBSM-2008102	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING - CHROMOSOMAL MICROARRAY ANALYSIS (CMA) AND NEXT-GENERATION SEQUENCING PANELS, FOR THE EVALUATION OF CHILDREN WITH DEVELOPMENTAL DELAY/INTELLECTUAL DISABILITY, AUTISM SPECTRUM DISORDER, AND/OR CONGENITAL ANOMALIES - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198824	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	90624 MENINGOCOCCAL PENTAVALENT VACCINE, MEN B-4C RECOMBINANT PROTEINS AND OUTER MEMBRANE VESICLE AND CONJUGATED MEN A, C, W, Y-DIPHTHERIA TOXOID CARRIER, FOR INTRAMUSCULAR USEPayerPolicy · BCBSM-2199274	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	SOMATIC BIOMARKER TESTING (INCLUDING LIQUID BIOPSY) FOR TARGETED TREATMENT AND IMMUNOTHERAPY IN METASTATIC COLORECTAL CANCER (KRAS, NRAS, BRAF, MMR/MSI, HER2, AND TMB) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2197832	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GERMLINE AND SOMATIC BIOMARKER TESTING (INCLUDING LIQUID BIOPSY) FOR TARGETED TREATMENT IN PROSTATE CANCER (BRCA1/2, HOMOLOGOUS RECOMBINATION REPAIR GENE ALTERATIONS), NTRK GENE FUSIONPayerPolicy · BCBSM-2183047	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING - CHROMOSOMAL MICROARRAY (CMA) ANALYSIS AND NEXT-GENERATION SEQUENCING PANELS, FOR THE EVALUATION OF CHILDREN WITH DEVELOPMENTAL DELAY/INTELLECTUAL DISABILITY, AUTISM SPECTRUM DISORDER, AND/OR CONGENITAL ANOMALIESPayerPolicy · BCBSM-2003173	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	DRUG COATED BALLOON FOR BENIGN PROSTATIC HYPERPLASIA LOWER URINARY TRACT SYMPTOMS & URETHRAL STRICTURES (I.E., OPTILUME DRUG COATED BALLOON) (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209362-A6764802A3	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	SCREENING FOR LUNG CANCER AND PULMONARY NODULE EVALUATION USING LOW DOSE COMPUTED TOMOGRAPHY (CT) SCANNING AND COMPUTER AIDED DETECTION (CAD) (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209379-FA6621C8D2	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GERMLINE GENETIC TESTING FOR GENE VARIANTS ASSOCIATED WITH BREAST CANCER IN INDIVIDUALS AT MODERATE AND HIGH BREAST CANCER RISK (E.G., CHEK2, ATM, BARD1, ETC.) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2198905	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	SOMATIC BIOMARKER TESTING (INCLUDING LIQUID BIOPSY) FOR TARGETED TREATMENT IN METASTATIC COLORECTAL CANCER (KRAS, NRAS,BRAF, NTRK, RET AND HER2)PayerPolicy · BCBSM-2203597	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (E.G., CEFALY, ETNS, AXON) AND TRANSCUTANEOUS AFFERENT PATTERNED STIMULATION (E.G., CALA ONE, CALA TRIO CALA KLQ)- MEDICARE ADVANTAGEPayerPolicy · BCBSM-2201631	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	90759 - HEPATITIS B VACCINE (HEPB), 3-ANTIGEN (S, PRE-S1, PRE-S2) 10 MCG DOSAGE, 3 DOSE SCHEDULE, FOR INTRAMUSCULAR USEPayerPolicy · BCBSM-2161422	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GERMLINE AND SOMATIC BIOMARKER TESTING (INCLUDING LIQUID BIOPSY) FOR TARGETED TREATMENT IN PROSTATE CANCER (BRCA1/2, HOMOLOGOUS RECOMBINATION REPAIR GENE ALTERATIONS) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2197830	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	MEASUREMENT OF LIPOPROTEIN-ASSOCIATED PHOSPHOLIPASE A2 (LP-PLA2) AND SECRETORY TYPE II PHOSPHOLIPASE A2 (SPLA2-IIA) IN THE ASSESSMENT OF CARDIOVASCULAR RISK - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2197060	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	SOMATIC BIOMARKER TESTING (INCLUDING LIQUID BIOPSY) FOR TARGETED TREATMENT AND IMMUNOTHERAPY IN METASTATIC COLORECTAL CANCER (KRAS, NRAS, BRAF, MMR/MSI, HER2, AND TMB)PayerPolicy · BCBSM-2022187	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (E.G., CEFALY, ETNS, AXON) AND TRANSCUTANEOUS AFFERENT PATTERNED STIMULATION (E.G., CALA ONE, CALA TRIO, CALA KLQ,)PayerPolicy · BCBSM-2199089	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	MULTIMARKER SERUM-BASED TESTING RELATED TO OVARIAN CANCER (E.G., OVA1, OVERA, OVAWATCH, GLYCOKNOW OVARIAN AND ROMA TESTING) (EFFECTIVE 07/01/2026)PayerPolicy · BCBSM-2209378-392273413B	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GERMLINE GENETIC TESTING FOR GENE VARIANTS ASSOCIATED WITH BREAST CANCER IN INDIVIDUALS AT MODERATE AND HIGH BREAST CANCER RISK (E.G., CHEK2, ATM, BARD1, ETC.)PayerPolicy · BCBSM-2117516	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GERMLINE AND SOMATIC BIOMARKER TESTING (INCLUDING LIQUID BIOPSY) FOR TARGETED TREATMENT IN OVARIAN CANCER (BRCA1, BRCA2, HOMOLOGOUS RECOMBINATION DEFICIENCY) - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2197829	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	GENETIC TESTING NONINVASIVE PRENATAL SCREENING FOR FETAL ANEUPLOIDIES, MICRODELETIONS, SINGLE-GENE DISORDERS, AND TWIN ZYGOSITY USING CELL-FREE FETAL DNAPayerPolicy · BCBSM-2058206	New policy
Aug 2, 2026	Blue Cross Blue Shield of Michigan and Blue Care Network	BMT - HEMATOPOIETIC CELL TRANSPLANTATION FOR PLASMA CELL DYSCRASIAS, INCLUDING MULTIPLE MYELOMA, PLASMA CELL LEUKEMIA, PLASMACYTOMA, AND POEMS SYNDROME - MEDICARE ADVANTAGEPayerPolicy · BCBSM-2195789	New policy